CRIS Current Research Information System

LEWIS, RUSSEL EDWARD
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.924
AS - Asia 4.987
EU - Europa 4.605
SA - Sud America 481
AF - Africa 381
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 18.401
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.853
SG - Singapore 1.531
GB - Regno Unito 1.414
VN - Vietnam 1.369
CN - Cina 1.179
DE - Germania 684
IT - Italia 595
SE - Svezia 558
HK - Hong Kong 369
BR - Brasile 341
RU - Federazione Russa 325
IN - India 308
IE - Irlanda 221
FR - Francia 209
ZA - Sudafrica 141
EE - Estonia 112
UA - Ucraina 83
CI - Costa d'Avorio 78
NL - Olanda 71
FI - Finlandia 69
AR - Argentina 65
BG - Bulgaria 60
EG - Egitto 59
TG - Togo 44
AT - Austria 41
CA - Canada 37
JP - Giappone 36
JO - Giordania 32
CH - Svizzera 31
ES - Italia 31
ID - Indonesia 31
BE - Belgio 29
EC - Ecuador 22
CL - Cile 21
MX - Messico 21
NG - Nigeria 19
KR - Corea 18
RO - Romania 17
SC - Seychelles 16
AU - Australia 15
BD - Bangladesh 13
CO - Colombia 13
PL - Polonia 13
TR - Turchia 12
LB - Libano 10
IQ - Iraq 8
LT - Lituania 8
MY - Malesia 8
PK - Pakistan 8
GR - Grecia 7
IR - Iran 7
TN - Tunisia 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
HU - Ungheria 6
PH - Filippine 6
IL - Israele 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
HN - Honduras 4
KZ - Kazakistan 4
UY - Uruguay 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DO - Repubblica Dominicana 3
KE - Kenya 3
KG - Kirghizistan 3
KW - Kuwait 3
LI - Liechtenstein 3
PE - Perù 3
PT - Portogallo 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AL - Albania 2
BO - Bolivia 2
EU - Europa 2
LY - Libia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MR - Mauritania 1
NE - Niger 1
NI - Nicaragua 1
Totale 18.392
Salva come PNG Salva come JPEG
Città #
Southend 1.274
Fairfield 1.141
Singapore 965
Ashburn 796
Woodbridge 485
Wilmington 483
Chandler 479
Seattle 419
Houston 414
Cambridge 378
Hong Kong 364
Dong Ket 338
Princeton 319
Ho Chi Minh City 271
Ann Arbor 267
Hanoi 231
Dublin 220
Boardman 204
Santa Clara 199
Beijing 178
Bologna 143
Westminster 134
Nanjing 115
Los Angeles 107
Berlin 104
Padova 96
New York 83
Jinan 82
Dallas 79
Abidjan 78
Shenyang 73
Redondo Beach 71
Dearborn 68
Saint Petersburg 67
Buffalo 59
Helsinki 58
Sofia 58
Cairo 57
San Diego 54
Hebei 48
Nanchang 46
Lomé 44
Changsha 40
Nuremberg 37
Falls Church 35
Chicago 33
Amman 32
Bremen 32
Redmond 32
Shanghai 32
Yubileyny 30
Olalla 28
Brussels 27
Da Nang 27
Hefei 27
Jiaxing 27
Medford 27
Munich 27
São Paulo 27
Florence 26
Guangzhou 26
Tokyo 26
Des Moines 24
Quận Bình Thạnh 24
Tianjin 24
Vienna 23
Zhengzhou 23
Frankfurt am Main 22
Jakarta 21
Milan 21
Ninh Bình 21
Ha Long 20
Turin 20
Ningbo 19
Abeokuta 18
Haiphong 18
Redwood City 18
Rome 18
San Francisco 18
Biên Hòa 17
Bühl 17
Bern 16
Buenos Aires 15
Haikou 14
Kunming 14
London 14
Phoenix 14
Taizhou 14
Toronto 14
Brooklyn 13
Hải Dương 13
Lanzhou 13
Vũng Tàu 13
Fuzhou 12
Hangzhou 12
Quito 12
Quận Một 11
Bắc Giang 10
Casalecchio di Reno 10
Leganés 10
Totale 12.377
Salva come PNG Salva come JPEG
Nome #
How I treat mucormycosis 306
Antifungal agents 252
Acute Invasive Fungal Rhinosinusitis in Immunocompromised Patients: Role of an Early Diagnosis 225
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 222
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 209
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 204
Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients 201
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 198
Pharmacokinetic-pharmacodynamic optimization of triazole antifungal therapy 196
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 195
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 180
Toll-deficient Drosophila are resistant to infection by Pneumocystis spp. Additional evidence of specificity to mammalian hosts 176
Characterization of antibody response in neuroinvasive infection caused by Toscana virus 173
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies 172
Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould disease 170
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 168
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 166
Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells 163
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 162
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 162
Computerized tomographic pulmonary angiography discriminates invasive mould disease of the lung from lymphoma 161
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 159
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 158
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 158
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study 156
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 156
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 151
Animal Models for Studying Triazole Resistance in Aspergillus fumigatus 150
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature 148
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 145
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 144
A risk prediction score for invasive mold disease in patients with hematological malignancies 144
Activity of Deferasirox in Mucorales: Influences of Species and Exogenous Iron 141
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia 141
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 140
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 139
Invasive Mucormycosis. In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th Edition 137
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 136
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 135
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 134
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida. 131
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 131
Aggressive versus conservative initiation of antibiotics 130
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 129
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation with Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015 128
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies 128
Reply to "Risk for Invasive Fungal Infections during Acute Myeloid Leukemia Induction Therapy: a True Association with Echinocandins?" 126
Retrospective cohort analysis of liposomal amphotericin b nephrotoxicity in patients with hematological malignancies 125
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians 124
Anidulafungin versus Caspofungin in a Mouse Model of Candidiasis Caused by Anidulafungin-Susceptible Candida parapsilosis Isolates with Different Degrees of Caspofungin Susceptibility 122
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline 119
Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection 117
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 117
Comparative Pharmacodynamics of Posaconazole in Neutropenic Murine Models of Invasive Pulmonary Aspergillosis and Mucormycosis 116
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus 115
Development and applications of prognostic risk models in the management of invasive mold disease 115
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 114
Breakthrough invasive mold infections in the hematology patient: Current concepts and future directions 114
Efficacy of Caspofungin in Neutropenic and Corticosteroid-Immunosuppressed Murine Models of Invasive Pulmonary Mucormycosis 111
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 111
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress? 110
Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis 109
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates 109
Mucorales-specific T cells in patients with hematologic malignancies 109
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 109
Predictors of mortality in multidrug-resistantKlebsiella pneumoniaebloodstream infections 108
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 108
Serum Galactomannan Diagnosis of Breakthrough Invasive Fungal Disease 107
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 107
A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study 107
Combination Therapy for Mucormycosis: Why, What, and How? 105
Proangiogenic Growth Factors Potentiate In Situ Angiogenesis and Enhance Antifungal Drug Activity in Murine Invasive Aspergillosis 105
Live monitoring and analysis of fungal growth, viability, and mycelial morphology using the incucyte neurotrack processing module 105
Azole-resistance in Aspergillus terreus and related species: An emerging problem or a rare Phenomenon? 105
Fungal Drug Resistance and Pharmacologic Considerations of Dosing Newer Antifungal Therapies 104
Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches 102
Future Directions in Mucormycosis Research 101
Treatment principles for the management of mold infections 101
Importance of Pharmacokinetic Considerations for Selecting Therapy in the Treatment of Invasive Fungal Infections 100
Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance 100
Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic? 100
Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis 100
Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art 99
In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods 99
Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species 99
Current Concepts in Antifungal Pharmacology 99
null 98
Antifungal agents:triazoles 98
Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia 97
Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzae 97
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines 96
null 96
Hyperthermia Sensitizes Rhizopus oryzae to Posaconazole and Itraconazole Action through Apoptosis 95
Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma 95
How Does Antifungal Pharmacology Differ for Mucormycosis Versus Aspergillosis? 95
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 95
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 95
In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates 94
Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis 94
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B 94
Totale 13.302
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.173
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.185 0 0 0 0 0 48 54 79 160 106 82 656
2021/20222.654 188 61 166 178 275 154 90 209 134 210 475 514
2022/20232.420 251 305 130 361 183 185 79 170 439 74 155 88
2023/2024761 67 129 46 64 67 137 108 18 17 42 45 21
2024/20252.696 105 575 212 239 384 175 184 74 37 132 117 462
2025/20263.429 855 474 655 489 728 228 0 0 0 0 0 0
Totale 18.816